Profiel
Doug Mendenhall worked as the Chief Scientific Officer at Patheon, Inc. from 2009 to 2010.
He received his undergraduate degree from the University of Washington and his graduate and doctorate degrees from the University of Kansas.
Eerdere bekende functies van Doug Mendenhall
Bedrijven | Functie | Einde |
---|---|---|
PATHEON, INC. | Hoofd Techniek/Wetenschap/O&O | 15-04-2010 |
Opleiding van Doug Mendenhall
University of Kansas | Doctorate Degree |
University of Washington | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Patheon, Inc.
Patheon, Inc. Pharmaceuticals: MajorHealth Technology Patheon, Inc. provides drug development and manufacturing services to global pharmaceutical, biotechnology and specialty pharmaceutical companies. It operates through two segments: Commercial Manufacturing Outsourcing and Pharmaceutical Development Services. The Commercial Manufacturing Outsourcing segment manufactures prescription products in sterile dosage forms as well as solid and liquid conventional dosage forms. The Pharmaceutical Development Services segment provides a broad range of development services, including solid and sterile dosage forms. The company operates through four market segments: Biologics, Emerging Pharma, Generics and Large Pharma. Patheon was founded in 1974 and is headquartered in Mississauga, Canada. | Health Technology |